Zhang, J., Zimmermann, B., Galletti, G., Halabi, S., Gjyrezi, A., Yang, Q., … Giannakakou, P. (2022). Liquid biopsy transcriptomics identify pathways associated with poor outcomes and immune phenotypes in men with mCRPC. In CANCER RESEARCH (Vol. 82).

Zhang, Jiaren, Bob Zimmermann, Giuseppe Galletti, Susan Halabi, Ada Gjyrezi, Qian Yang, Santosh Gupta, et al. “Liquid biopsy transcriptomics identify pathways associated with poor outcomes and immune phenotypes in men with mCRPC.” In CANCER RESEARCH, Vol. 82, 2022.

Zhang J, Zimmermann B, Galletti G, Halabi S, Gjyrezi A, Yang Q, et al. Liquid biopsy transcriptomics identify pathways associated with poor outcomes and immune phenotypes in men with mCRPC. In: CANCER RESEARCH. 2022.

Zhang, Jiaren, et al. “Liquid biopsy transcriptomics identify pathways associated with poor outcomes and immune phenotypes in men with mCRPC.” CANCER RESEARCH, vol. 82, no. 12, 2022.

Zhang J, Zimmermann B, Galletti G, Halabi S, Gjyrezi A, Yang Q, Gupta S, Verma A, Sboner A, Anand M, George DJ, Gregory SG, Mahtani P, Hong S, Pascual V, Mavragani CP, Antonarakis ES, Nanus DM, Tagawa ST, Elemento O, Armstrong AJ, Giannakakou P. Liquid biopsy transcriptomics identify pathways associated with poor outcomes and immune phenotypes in men with mCRPC. CANCER RESEARCH. 2022.